Paper Details

  1. Home
  2. Paper Details

Rizatriptan in the treatment of migraine.

Author: DahlofC G, LinesC R, RapoportA M, SheftellF D

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Rizatriptan, a selective 5-hydroxytriptamine1B/1D receptor agonist, effectively relieves headache pain and associated migraine symptoms in adults. The 10-mg dose is more effective than the 5-mg dose. Rizatriptan is generally well-tolerated with most side effects being mild or moderate and transitory.
Paper Details　
Original Abstract of the Article :
Rizatriptan is a selective 5-hydroxytriptamine1B/1D receptor agonist that was launched in 1998 for the acute treatment of migraine in adults. Based on data from 6 large clinical trials in patients > or =18 years of age in whom migraine was diagnosed according to International Headache Society criter...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/S0149-2918(00)86731-4

データ提供：米国国立医学図書館（NLM）

Rizatriptan: A New Oasis in the Desert of Migraine Relief

Migraine headaches are a debilitating condition, often described as a relentless sandstorm, causing severe pain and discomfort. This study explores the potential of rizatriptan, a selective 5-hydroxytriptamine1B/1D receptor agonist, as an effective treatment for migraine headaches. The authors reviewed data from six large clinical trials involving rizatriptan, finding that it effectively relieved headache pain and associated migraine symptoms, offering a potential oasis of relief in the desert of migraine pain.

The study also found that rizatriptan was generally well tolerated, with few side effects, providing a safe and effective treatment option for individuals with migraine. This research is like discovering a hidden spring in the desert, offering a source of relief for those struggling with migraine.

Finding a Path to Relief in the Desert of Migraine: Rizatriptan Offers Hope

The study's findings provide a valuable roadmap for treating migraine headaches, offering a potential solution to reduce the impact of this debilitating condition. The discovery of rizatriptan is like finding a new trail through the desert, guiding us towards a more comfortable and manageable experience for those affected by migraine.

Navigating the Desert of Migraine: Finding a Path to Relief

This study highlights the importance of ongoing research in the field of migraine treatment. By developing new and effective medications like rizatriptan, we can create a more serene and manageable desert landscape for those affected by this challenging condition.

Dr.Camel's Conclusion

This study is a beacon of hope in the vast desert of migraine research. It offers a potential oasis of relief for those struggling with this debilitating condition, paving the way for a more comfortable and manageable future.

Date :
  1. Date Completed 2000-07-27
  2. Date Revised 2012-11-15
Further Info :

Pubmed ID

10890255

DOI: Digital Object Identifier

10.1016/S0149-2918(00)86731-4

Related Literature

Article Analysis
・Side Effects of rizatriptan
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.